Loading insider details...
Beta
Latest Form 4 (Aug 25, 2026): Exercise/Conversion of 17,218 NBP shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 25, 2026 | NovaBridge Biosciences (NBP) | Exercise/Conversion | 17,218 | n/a |
| Jun 5, 2026 | LB PHARMACEUTICALS INC (LBRX) | Grant/Award | 12,500 | n/a |
| Mar 10, 2026 | LB PHARMACEUTICALS INC (LBRX) | Grant/Award | 20,000 | n/a |
| Feb 20, 2025 | Neumora Therapeutics, Inc. (NMRA) | Sale | 5,614 | $9.4K |
| Feb 18, 2025 | Neumora Therapeutics, Inc. (NMRA) | Disposition to Issuer | 502,934 | n/a |
| Oct 11, 2024 | Neumora Therapeutics, Inc. (NMRA) | Sale | 5,563 | $83.5K |
| Sep 19, 2024 | Neumora Therapeutics, Inc. (NMRA) | Sale | 30,788 | $363.7K |
| Sep 16, 2024 | Neumora Therapeutics, Inc. (NMRA) | Sale | 32,948 | $376.7K |
| Feb 16, 2024 | Neumora Therapeutics, Inc. (NMRA) | Grant/Award | 50,000 | n/a |
| Sep 18, 2023 | Neumora Therapeutics, Inc. (NMRA) | Grant/Award | 352,941 | n/a |